All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AVZO-021Phase 22 trials

    Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor

  • AZD0171MSC-1Phase 22 trials

    AstraZeneca · Non-small Cell Lung Cancer, Locally Advanced or Metastatic Solid Tumours

  • AZD0292Phase 22 trials

    AstraZeneca · Bronchiectasis With Pseudomonas Aeruginosa Colonization

  • AZD2287Imaging agentPhase 22 trials

    AstraZeneca · Metastatic Prostate Cancer

  • AZD2389Phase 22 trials

    AstraZeneca · Liver Fibrosis, Hepatic Cirrhosis

  • AZD3470Phase 22 trials

    AstraZeneca · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

  • AZD5004Phase 22 trials

    AstraZeneca · Obesity or Overweight, Diabetes Mellitus, Type 2

  • AZD7798Phase 22 trials

    AstraZeneca · Moderate to Severe Crohn's Disease, Crohn's Disease

  • AzeliragonPhase 22 trials

    Cantex Pharmaceuticals · Glioblastoma

  • B1962Phase 22 trials

    Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers

  • B7-H3 CAR-NKEB-G3B7-NK dual-target CAR-NK cells, Dual-target GPC3Phase 22 trials

    Beijing Biotech · Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer, Relapsed Neuroblastoma

  • BCMA-CD19-IL-15Phase 22 trials

    iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)

  • BelvarafenibHM95573Phase 22 trials

    Hanmi Pharmaceutical Company Limited · Advanced or Metastatic Melanoma, Solid Tumors

  • bexmarilimabFP-1305Phase 22 trials

    Faron Pharmaceuticals Ltd · Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia

  • BEY1107Phase 22 trials

    BeyondBio Inc. · Metastatic Colorectal Cancer, Locally Advanced or Metastatic Pancreatic Cancer

  • BGE-102Phase 22 trials

    BioAge Labs, Inc. · Diabetic Macular Edema (DME), Obesity and Cardiovascular Risk

  • BI 1569912Phase 22 trials

    Boehringer Ingelheim · Depressive Disorder, Major

  • BimagrumabLY3985863, BYM338Phase 22 trials

    Eli Lilly · Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction

  • BivamelagonLB54640Phase 22 trials

    Rhythm Pharmaceuticals, Inc. · Hypothalamic Obesity

  • BL-M09D1Phase 22 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gynecological Malignancies, Urothelial Carcinoma (UC)

  • BL1107Phase 22 trials

    Bausch & Lomb Incorporated · Dry Eye Disease, Glaucoma

  • BLEX 404Phase 22 trials

    Rgene Corporation · Pancreatic Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung

  • BLEX 404 LiquidPhase 22 trials

    BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer

  • BLU-808Phase 22 trials

    Blueprint Medicines Corporation · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Allergic Rhinoconjunctivitis

  • BMB-101Phase 22 trials

    Bright Minds Biosciences Pty Ltd · Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome

  • BMF-219Phase 22 trials

    Biomea Fusion Inc. · Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus

  • BMN 351Phase 22 trials

    BioMarin · Duchenne Muscular Dystrophy (DMD), Duchenne Muscular Dystrophy

  • BMS-986158Phase 22 trials

    Bristol Myers Squibb · Myelofibrosis, Multiple Myeloma

  • BMS-986368CC-97489Phase 22 trials

    Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity

  • BNT166aPhase 22 trials

    BioNTech SE · Mpox (Monkeypox), Smallpox, Orthopoxvirus Infection

  • BNT326Phase 22 trials

    BioNTech SE · Advanced Solid Tumor, Non-small Cell Lung Cancer

  • BPL-003Phase 22 trials

    Beckley Psytech Limited · Treatment Resistant Depression

  • BreakVaxPhase 22 trials

    BreakBio Corp · Triple-Negative Breast Cancer (TNBC), Glioblastoma (GBM)

  • BRII-179Phase 22 trials

    Brii Biosciences Limited · Chronic Hepatitis B Virus (HBV) Infection, For Treatment of Chronic Hepatitis B Virus Infection

  • BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials

    Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive

  • BS01Phase 22 trials

    Bionic Sight LLC · Retinitis Pigmentosa, Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)

  • BT7480Phase 22 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor

  • C-CAR168Phase 22 trials

    AbelZeta Inc. · Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases

  • CAB-AXL-ADCBA3011Phase 22 trials

    BioAtla, Inc. · Non-Small-Cell Lung Cancer, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma

  • CadefrecitinibGLPG3667Phase 22 trials

    Lakefront Biotherapeutics NV · Dermatomyositis, Systemic Lupus Erythematosus

  • CamonsertibRP-3500Phase 22 trials

    Roche (Genentech) · Solid Tumors, Advanced Solid Tumor

  • CamoteskimabAPL-9109Phase 22 trials

    Apollo Therapeutics Ltd · Atopic Dermatitis, Atopic, Dermatitis

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • ImmunityBio, Inc. · Relapsed B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non Hodgkin Lymphoma

  • CDR132LPhase 22 trials

    Novo Nordisk · Heart Failure

  • CGB-500Phase 22 trials

    CAGE Bio Inc. · Atopic Dermatitis (AD)

  • Checkpoint InhibitorPhase 22 trials

    EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms

  • CIL001palirodenPhase 22 trials

    Cilcare SAS · Cochlear Synaptopathy, Tinnitus, Bilateral

  • CIN-102 DosePhase 22 trials

    CinDome Pharma, Inc. · Idiopathic Gastroparesis, Diabetic Gastroparesis

  • CIT-013Phase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

NewerPage 34 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.